Excess neurological death in New York City after the emergence of COVID-19
J Neurol
.
2021 Jun;268(6):2026-2028.
doi: 10.1007/s00415-020-10084-2.
Epub 2020 Jul 20.
Authors
Adam de Havenon
1
,
John P Ney
2
,
Brian Callaghan
3
,
Shadi Yaghi
4
,
Jennifer J Majersik
5
Affiliations
1
Department of Neurology, University of Utah, 175 N. Medical Dr., Salt Lake City, UT, 84132, USA. adam.dehavenon@hsc.utah.edu.
2
Department of Neurology, Boston University, Boston, USA.
3
Department of Neurology, University of Michigan, Ann Arbor, USA.
4
Department of Neurology, New York University, New York City, USA.
5
Department of Neurology, University of Utah, 175 N. Medical Dr., Salt Lake City, UT, 84132, USA.
PMID:
32691234
PMCID:
PMC7370626
DOI:
10.1007/s00415-020-10084-2
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Mortality
Nervous System Diseases* / mortality
New York City / epidemiology
SARS-CoV-2
Grants and funding
K23 NS105924/NS/NINDS NIH HHS/United States
U24 NS107228/NS/NINDS NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States
K23NS105924/NS/NINDS NIH HHS/United States